Face Perception vs. Memory Training to Improve Face Recognition in Developmental Prosopagnosia

Sponsor
Boston VA Research Institute, Inc. (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05800782
Collaborator
(none)
72
1
3
22.3
3.2

Study Details

Study Description

Brief Summary

The goal of this study is to test the effectiveness of two experimental training programs aimed at improving face processing in developmental prosopagnosia (perception training, memory training) in comparison to an active control. The investigators will use a longitudinal design and randomize developmental prosopagnosics to three parallel arms: active control, perception training and memory training.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Face Memory Training
  • Behavioral: Face Perception Training
  • Behavioral: Placebo control training
N/A

Detailed Description

The investigators propose a longitudinal design with three parallel arms: active control, perception training and memory training. To maximize power, developmental prosopagnosics (DPs) in the active control group will be subsequently be offered training. Pre-training/control assessments will be performed and within 2 weeks, DPs will be randomized to one of the three training conditions. Next, all DPs will complete 6-weeks of their assigned intervention. The research assistant will provide coaching at least once per week. DPs will be assessed within two weeks of training completion and after a 12-week no-contact period. For those in the active control group, the no-contact period will serve to wash out any placebo effect and Assessment 3 will be used as their new baseline. These DPs will then be randomized to perception or memory training. Assessments will then be given to these DPs within a week after intervention completion and after a 12 weeks no-contact period.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
There will be a pre assessment, 6 weeks of training/active control, then an immediate post assessment, and finally an assessment after a 12-week no-contact periodThere will be a pre assessment, 6 weeks of training/active control, then an immediate post assessment, and finally an assessment after a 12-week no-contact period
Masking:
Single (Participant)
Masking Description:
Participants will not be told whether they are in the experimental or control conditions and all conditions will require discriminating faces.
Primary Purpose:
Treatment
Official Title:
Examining the Effectiveness of Face Perception and Memory Training to Improve Face Recognition in Developmental Prosopagnosia
Anticipated Study Start Date :
Apr 15, 2023
Anticipated Primary Completion Date :
Feb 1, 2025
Anticipated Study Completion Date :
Feb 21, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Memory Training

Participants will perform 6 weeks of face memory training (5 x 40 min sessions/week) that targets enhancing encoding to improve face recollection. As training progresses, the repetition lags (spaces between repeated foil faces) and number of faces will increase.

Behavioral: Face Memory Training
Computer-based training using faces targeting face memory

Active Comparator: Perception Training

Participants will perform 6 weeks of face perception training (5 x 40 min sessions/week) that require discriminating faces based on internal features (e.g., eyebrow-eye distance). As training progresses, the faces will become more challenging and the face sizes will vary.

Behavioral: Face Perception Training
Computer-based training using faces targeting improving face perception

Placebo Comparator: Active Control Training

Participants will perform 6 weeks of face perception training (5 x 40 min sessions/week) that require discriminating faces based on external facial features (e.g., hair). As training progresses, the faces will become more challenging and the face sizes will vary.

Behavioral: Placebo control training
Computer-based training using faces not targeting improving face perception or memory

Outcome Measures

Primary Outcome Measures

  1. Change in Cambridge Face Memory Test from baseline to post-training [baseline, within 2 weeks post-training (approximately 10 weeks after baseline), 12 weeks after training ends (approximately 22 weeks after baseline)]

    unfamiliar face learning/memory test, Cambridge Face Memory Test, minimum=0/maximum=72, higher is better performance

  2. Change in Face Perception from baseline to post-training [baseline, within 2 weeks post-training (approximately 10 weeks after baseline), 12 weeks after training ends (approximately 22 weeks after baseline)]

    computerized Benton Face Recognition Test, minimum=0/maximum=54, higher is better performance

Secondary Outcome Measures

  1. Change in Face Recollection from baseline to post-training [baseline, within 2 weeks post-training (approximately 10 weeks after baseline), 12 weeks after training ends (approximately 22 weeks after baseline)]

    face recollection measure derived from old/new unfamiliar face recognition test

  2. Change in Self-reported face recognition ability from baseline to post-training [baseline, within 2 weeks post-training (approximately 10 weeks after baseline),12 weeks after training ends (approximately 22 weeks after baseline)]

    items assessing everyday face recognition, minimum=0/maximum=100, higher is better

  3. Change in Eye processing ability from baseline to post-training [baseline, within 2 weeks post-training (approximately 10 weeks after baseline), 12 weeks after training ends (approximately 22 weeks after baseline)]

    average eye processing ability from Georges task

  4. Change in Holistic processing from baseline to post-training [baseline, within 2 weeks post-training (approximately 10 weeks after baseline), 12 weeks after training ends (approximately 22 weeks after baseline)]

    measure of holistic processing of faces (holistic advantage) from part-whole task

  5. Change in NIH PROMIS Social functioning self-report from baseline to post-training [baseline, within 2 weeks post-training (approximately 10 weeks after baseline), 12 weeks after training ends (approximately 22 weeks after baseline)]

    bank of NIH PROMIS items asking about social functioning related to prosopagnosia, minimum=0/maximum=100, higher is better

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged 18-90

  • Have lifelong histories of face recognition difficulties that impact everyday life (i.e., not associated with some event such as a stroke, seizure, etc)

  • Score > 2 standard deviations below the mean on the famous faces test and Cambridge Face Memory Test. This is in line with our previous studies and others in the literature.

Exclusion Criteria:
  • History of a significant neurological disorder including hydrocephalus, stroke, moderate to severe traumatic brain injury (TBI), severe neuromuscular diseases, or severe hypoxia due to cardiac arrest.

  • Participants with a history of mild TBI or simple concussion will not be excluded as long as it was > 6 months ago and as long as they have not had repeated concussions (>5).

  • Participants will be excluded if they have impairments that interfere with cognitive performance, such as uncorrected hearing or vision, lack of English proficiency, musculoskeletal or other issues.

  • Additionally, participants will be excluded if they have psychiatric disorders, such as schizophrenia, major depressive disorder, bipolar disorder, chronic intractable obsessive-compulsive disorder, or agoraphobia.

  • Participants with a diagnosis of ADHD will be included as long as their medication has been consistent for the past 6 months.

  • Participants who are currently dependent on alcohol or other substances will be excluded, as this may negatively impact cognitive performance.

  • Participants who currently are, or within the last 6 months, participating in a behavioral or pharmacological intervention will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Boston Healthcare System Boston Massachusetts United States 02130

Sponsors and Collaborators

  • Boston VA Research Institute, Inc.

Investigators

  • Principal Investigator: Joseph DeGutis, Ph.D., Harvard Medical School/VA Boston Healthcare Systems

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Boston VA Research Institute, Inc.
ClinicalTrials.gov Identifier:
NCT05800782
Other Study ID Numbers:
  • R01EY032510-02
First Posted:
Apr 6, 2023
Last Update Posted:
Apr 6, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 6, 2023